Skip to main content
padlock icon - secure page this page is secure

Open Access Tetanus Antibody in Nigerians Living with HIV/AIDS: A Preliminary Report

Download Article:

The full text article is available externally.

The article you have requested is supplied via the DOAJ. View from original source.

This article is Open Access under the terms of the Creative Commons CC BY-NC licence.

The aim of this study is to investigate the need for anti-tetanus immunisation in Nigerians living with HIV/AIDS by quantifying antibody to tetanus organism in them. Both symptomatic and asymptomatic consenting Nigerians positive for HIV infection and aged 15 years and above were included in the study. Apparently healthy age- and sex-matched subjects were enrolled as controls. Immunisation history was recorded in all participants. The PCV, WBC, platelet and CD4+ cell counts were done on automated counter. Serum levels of antibody to tetanus were quantitated using standard ELISA method. There was no significant difference (t = 0.138, p = 0.89) in the mean serum levels of antibody to tetanus in patients with HIV/AIDS (0.5 ± 0.86 IU/mL) when compared with the controls (0.46 ± 0.52 IU/mL). About 85.7% (36/42) of patients with HIV/AIDS had protective tetanus antibody and only six (14.3%) had non-protective antibody levels. In patients with CD4+ T lymphocytes of < 200 cells/µL, the mean anti-tetanus antibody was 0.50 ± 0.98 IU/mL, while in those with CD4+ T lymphocytes of > 200 cells/µL, it was 0.53 ± 0.53 IU/mL. The difference was not statistically significant (t = 0.1, p = 0.918). The majority of our patients presented in advanced stage with 69% of them having CD4+ T lymphocytes < 200 cell/µL. This study found a significant number of Nigerians with HIV/AIDS having protective levels of antibody to tetanus in their sera. We therefore suggest continue efforts at improving on the National Programme on Immunisation, as immunisation in patients with HIV infection may not yield adequate responses and may be fraught with the risk of increase in viral replication.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Publication date: January 1, 2010

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more